"The US Food and Drug Administration (FDA) has expanded the indication for the short-acting beta-agonist albuterol sulfate inhalation powder (ProAir RespiClick, Teva) to children aged 4 to 11 years, the company announced today.
Acute overdose by inhalation is unlikely since ipratropium bromide is not well absorbed systemically after inhalation or oral administration.
ATROVENT HFA is contraindicated in the following conditions [see WARNINGS AND PRECAUTIONS].
- Hypersensitivity to ipratropium bromide or other ATROVENT HFA components
- Hypersensitivity to atropine or any of its derivatives
Last reviewed on RxList: 10/8/2012
Additional Atrovent HFA Information
Atrovent HFA - User Reviews
Atrovent HFA User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.